A Study to Evaluate Abuse Potential of Istradefylline

Status Completed

Clinical Trial Summary

This study is to evaluate the abuse potential of single-doses of istradefylline compared to placebo and phentermine in recreational stimulant users. Subjects will participate in an outpatient medical Screening visit, a 5-day Qualification (Drug Discrimination) Phase, a 6-period Treatment Phase, and an outpatient safety Follow-Up visit. Study will be approximately 25 weeks total. Within 28 days of the Screening visit, eligible subjects will be admitted to the CRU (Day -1) for the Qualification Phase. During the Qualification Phase, subjects will receive single oral doses of phentermine 60 mg and matching placebo in a randomized, double blind, crossover manner, with each drug administration separated by approximately 48 hours (Day 1 and Day 3), to ensure that they can discriminate and show positive subjective effects of the active controls. Following evaluation of eligibility, subjects may be discharged (those who fail Qualification criteria) or remain in the CRU (those who pass criteria and are eligible) and then proceed directly to the Treatment Phase. The washout interval between last drug administration in the Qualification Phase and first drug administration in the Treatment Phase will be at least 96 hours (4 days). Following confirmation of eligibility from the Qualification Phase, subjects will be randomized to one of 6 treatment sequences according to a 6x6 Williams square. Subjects will receive single oral doses of each of the 6 treatments in a randomized, double-blind, crossover manner, Istradefylline 40 mg, Istradefylline 80 mg, Istradefylline 160 mg, Phentermine 45 mg, Phentermine 90 mg, Placebo. Each drug administration will be separated by at least 21 days. Serial pharmacodynamic evaluations will be conducted up to 24 hours after each study drug administration to confirm exposure to istradefylline.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02609477
Study type	Interventional
Source	Kyowa Kirin Co., Ltd.
Contact
Status	Completed
Phase	Phase 1
Start date	January 2016
Completion date	July 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02282306` - Phone Interview to Prevent Recurring Opioid Overdoses	N/A
Completed	`NCT02224508` - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks	N/A
Completed	`NCT02375516` - Preventing Drug Abuse Among Hispanic Adolescents	N/A
Completed	`NCT01442753` - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth	N/A
Withdrawn	`NCT01275391` - cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use	Phase 1/Phase 2
Completed	`NCT00907309` - Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use	Phase 1/Phase 2
Completed	`NCT02228044` - Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment	N/A
Withdrawn	`NCT01427465` - Brief Integrative Alcohol Interventions for Adolescents	N/A
Completed	`NCT00350909` - Brief Intervention for Drug Abusing Adolescents	Phase 2
Completed	`NCT00148031` - Improving Hepatitis C Treatment in Injection Drug Users	Phase 4
Completed	`NCT00383838` - Self-Selected Brief Alcohol Intervention for Adolescents	N/A
Completed	`NCT00722644` - Cognitive Behavioral Stress Management for HIV+ Drug Abusers	Phase 1
Completed	`NCT00451854` - Student Athlete Testing Using Random Notification	N/A
Completed	`NCT01036711` - Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRI
Terminated	`NCT02741076` - Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain	Phase 4
Completed	`NCT01035723` - Effect of Functional Genetic Polymorphisms on Brain Morphology and Function
Completed	`NCT06044363` - Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders	N/A
Recruiting	`NCT05037487` - Evaluation of Smoked THC and CBD in Men and Women	Phase 1
Recruiting	`NCT04725266` - A Family-based Intervention for Drug-abusing Adults in Hong Kong	N/A
Completed	`NCT03678051` - CBT4CBT for Women in Residential Treatment for Substance Use Disorders	N/A